Sangamo Biosciences (SGMO) Misses Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. HUBS
4. NUE
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Sangamo Biosciences (SGMO) Misses Q2 EPS by 4c

Sangamo BioSciences Reports Second Quarter 2015 Financial Results

August 5, 2015 4:02 PM EDT

RICHMOND, Calif., Aug. 5, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its second quarter 2015 financial results and accomplishments.

For the second quarter ended June 30, 2015, Sangamo reported a consolidated net loss of $12.1 million, or $0.17 per share, compared to a net loss of $7.0 million, or $0.10 per share, for the same period in 2014. As of June 30, 2015, the Company had cash, cash equivalents, marketable securities and interest receivable of $218.6 million.

Revenues for the second quarter of 2015 were $8.4 million, compared to $10.4 million for the same... More

Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference

August 4, 2015 4:02 PM EDT

RICHMOND, Calif., Aug. 4, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and development, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 8:35am ET on Tuesday, August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare Conference. The... More